APA08 December 20140 view
miR-21 expression in tumour microenvironment is an indicator, according to US scientists.
Women with triple-negative breast cancer (TNBC) have a higher probability of worse clinical outcomes than other tumour subgroups. US scientists have therefore looked for predictive biomarkers and found that high levels of the microRNA miR-21 in the tumor microenvironment can be indicative of the disease’s progression. The findings have been published in “The American Journal of Pathology”.